Evidence map›Paper›PMID 41103655›Full record

ReviewFrontiers in endocrinology2025

The mechanism of oxidative stress in asthenozoospermia and antioxidant strategies: a review.

Linfeng Mo, Hongmei Wu, Mingxue Zhang, Peng Zhang, Wei Peng, Yonghua He, Feng Gao

Abstract readReview
In one paragraph

Review in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Linfeng Mo *Department of Health Management, Guangzhou Huashang Vocational College, Guangzhou, China.
Hongmei Wu *Department of Health Management, Guangzhou Huashang Vocational College, Guangzhou, China.
Mingxue ZhangDepartment of Health Management, Guangzhou Huashang Vocational College, Guangzhou, China.
Peng ZhangDepartment of Medical Records, Occupational Diseases Hospital of Shandong First Medical University/Shandong Province Hospital of Occupational Diseases, Jinan, China.
Wei PengDepartment of Medical Insurance and Price, Medical Center Hospital of Qionglai City, Chengdu, China.
Yonghua HeDepartment of Epidemiology and Health Statistics, Guilin Medical University, Guilin, China.
Feng GaoDepartment of Medical Records, Occupational Diseases Hospital of Shandong First Medical University/Shandong Province Hospital of Occupational Diseases, Jinan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asthenozoospermia, a leading cause of male infertility, is closely associated with oxidative stress (OS), which reflects an imbalance between reactive oxygen species (ROS) production and antioxidant capacity. ROS originate from both endogenous sources (e.g., inflammation and infection) and exogenous exposures (e.g., lifestyle and environmental pollutants). At physiological levels, ROS participate in key processes such as sperm proliferation, maturation, capacitation, acrosome reaction, and fertilization. However, excessive ROS become detrimental, damaging sperm membrane lipids, DNA integrity, and mitochondrial function, ultimately leading to reduced sperm motility and impaired fertility. A systematic understanding of the sources and mechanisms of ROS in asthenozoospermia is essential for developing targeted interventions. This review highlights the comprehensive integration of multiple ROS sources and their multi-level damaging effects, with a particular focus on mitochondrial dysfunction as a central mechanism in OS-induced sperm damage. Furthermore, we discuss the potential of antioxidant-based strategies and propose future directions for targeted therapies. This work aims to provide new insights into the treatment of asthenozoospermia and facilitate a shift from empirical management to mechanism-targeted therapies in clinical practice.

Indexed as

AntioxidantsAsthenozoospermiaOxidative StressAnimalsHumansMaleMitochondriaReactive Oxygen SpeciesSpermatozoaSperm MotilityAntioxidantsReactive Oxygen Speciesantioxidantsasthenozoospermiafertilityoxidative stresssperm motility

Identifiers

PMID41103655
PMCPMC12520966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.